文献速递甲状腺疾病

成人癌症幸存者中的第二原发分化型甲状腺癌:SEER数据库分析

Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该研究回顾性分析SEER数据库(2000-2017)数据,比较9253例第二原发分化型甲状腺癌(2-DTC)与138555例第一原发分化型甲状腺癌(1-DTC)的特征与结局。2-DTC患者年龄更大、男性及白人比例更高;仅4种既往原发恶性肿瘤与更高的侵袭性特征相关,19种则相反;2-DTC在III期和IV期显示对甲状腺癌特异性死亡的保护作用,多数既往原发恶性肿瘤的2-DTC甲状腺癌特异性死亡风险低于1-DTC,但许多既往原发恶性肿瘤的癌症特异性死亡风险更高。作者认为,鉴于2-DTC的特征与结局,对2-DTC(尤其既往原发恶性肿瘤死亡风险高者)进行积极治疗可能并不可取。

要点

  • 2-DTC患者相较1-DTC更年长、男性及白人比例更高(均P<.05)。
  • 仅4种既往原发恶性肿瘤与更高的DTC侵袭性特征相关,19种则相反(均P<.05)。
  • 2-DTC在III期(SHR 0.47;95%CI 0.27-0.83)和IV期(SHR 0.72;95%CI 0.52-0.99)对DTC特异性死亡有保护作用。

核心结论

  • 鉴于2-DTC的特征与结局,对2-DTC进行积极治疗可能并不可取,尤其是既往原发恶性肿瘤死亡风险高者。

研究设计与样本

  • 回顾性分析SEER数据库(2000-2017)数据,纳入138555例1-DTC和9253例2-DTC患者,2-DTC按既往原发恶性肿瘤分为25个亚组。

主要发现

  • 2-DTC患者相较1-DTC更年长、男性及白人比例更高(均P<.05)。
  • 多因素logistic回归中,仅4种既往原发恶性肿瘤与更高的DTC侵袭性特征发生率相关,19种则相反(均P<.05)。
  • 多因素竞争风险分析中,2-DTC在I期(SHR 1.16;95%CI 0.65-2.07)和II期(SHR 0.67;95%CI 0.45-1.01)无死亡风险,在III期(SHR 0.47;95%CI 0.27-0.83)和IV期(SHR 0.72;95%CI 0.52-0.99)有保护作用。
  • 多数发展为2-DTC的既往原发恶性肿瘤其DTC特异性死亡风险低于1-DTC,但许多既往原发恶性肿瘤的癌症特异性死亡风险更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adult cancer survivors are at a heightened risk for secondary primary differentiated thyroid carcinoma (2-DTC). The characteristics and outcomes of 2-DTC remain poorly understood. OBJECTIVE: We aimed to explore the characteristics and outcomes of 2-DTC. METHODS: We retrospectively analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2017). 2-DTC was divided into 25 subgroups based on prior primary malignancies (PPMs). Baseline characteristics were compared using the chi-square test. Multivariable logistic analysis was used to identified if PPMs were associated with aggressive DTC characteristics. DTC-specific and cancer-specific mortality were analyzed using a univariable and multivariable competing risk regression model. RESULTS: There were 138 555 1-DTC and 9253 2-DTC patients identified. 2-DTC patients were predominantly older, male, and White compared to first primary DTC (1-DTC) (all P < .05). In multivariable logistic regression analysis, only 4 types of PPMs were associated with higher rates of DTC aggressive characteristics, while 19 types exhibited lower rates (all P < .05). In multivariable competing risk analysis, 2-DTC showed no mortality risk in stages I (SHR: 1.16; 95% CI, 0.65-2.07) and II (SHR: 0.67; 95% CI, 0.45-1.01), but a protective role in stages III (SHR: 0.47; 95% CI, 0.27-0.83) and IV (SHR: 0.72; 95% CI, 0.52-0.99). Most PPMs that developed into 2-DTC had a lower risk of DTC-specific death than 1-DTC, but many PPMs had a higher risk of cancer-specific death. CONCLUSION: Given the characteristics and outcomes of 2-DTC, aggressive treatment for 2-DTC, particularly for PPM with a high mortality risk, may not be advisable.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Feng J, Wu C, Shen F, et al. Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis. J Clin Endocrinol Metab. 2025. PMID: 39047061. doi:10.1210/clinem/dgae501

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。